Pharmacogenomics, How to Deal with Different Types of Variants in Next Generation Sequencing Data in the Personalized Medicine Area
Pharmacogenomics (PGx) is the knowledge of diverse drug responses and effects in people, based on their genomic profiles. Such information is considered as one of the main directions to reach personalized medicine in future clinical practices. Since the start of applying next generation sequencing (...
Main Authors: | Alireza Tafazoli, Natalia Wawrusiewicz-Kurylonek, Renata Posmyk, Wojciech Miltyk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/1/34 |
Similar Items
-
Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response—A Genetic Survey
by: Alireza Tafazoli, et al.
Published: (2021-01-01) -
Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests
by: Alireza Tafazoli, et al.
Published: (2021-03-01) -
Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population
by: He C, et al.
Published: (2021-08-01) -
Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs
by: Wojciech Miltyk, et al.
Published: (2022-11-01) -
Pharmacogenomics and Personalized Medicine
by: Erika Cecchin, et al.
Published: (2020-06-01)